INKT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Mink Therapeutics Inc (INKT) is not a strong buy for a beginner, long-term investor at this moment. The technical indicators show a bearish trend, there is no significant trading sentiment or news catalyst, and the company's financials remain weak with no revenue and negative net income. While the stock has a chance for minor short-term gains, it does not align with a long-term investment strategy focused on growth or stability.
The technical indicators are bearish. The MACD histogram is negative and contracting, RSI is neutral at 32.317, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its support level (S1: 10.897, S2: 10.579) with resistance at R1: 11.924 and R2: 12.242.
NULL identified. No recent news or significant trading trends from hedge funds or insiders.
Bearish technical indicators, no revenue growth, and negative financial performance. Lack of recent news or influential trading activity.
In Q3 2025, the company reported no revenue growth (0% YoY), negative net income of -$2,887,709 (improved by 59.84% YoY), and an EPS of -0.65 (improved by 41.30% YoY). Gross margin remains at 0%. Overall, the financials are weak with no signs of profitability.
No data on analyst ratings or price target changes.
